Utah Patients Coalition
  • JOIN THE MOVEMENT
  • Donate
  • Resources
    • Plant Medicine
      • Cannabis
      • Psilocybin + Entheogens
    • Legislature
      • Medical Cannabis Act
      • Psychotherapy Drug Task Force
    • Events
  • Services & Programs
    • Utah Patients Subsidy Program
    • Political Action Committee
  • About Us
    • Contact
    • Meet Our Team
  • Blog
Select Page
FDA Anticipated to Approve Psilocybin for Depression Within 2 Years

FDA Anticipated to Approve Psilocybin for Depression Within 2 Years

Aug 24, 2022 | In the News

The FDA is anticipated to approve psilocybin as a therapeutic drug to treat depression within the next two years. This news comes from an official letter sent by the Substance Abuse and Mental Health Services Administration. The letter has many interesting statements,...
What is Utah’s Mental Illness Psychotherapy Drug Task Force?

What is Utah’s Mental Illness Psychotherapy Drug Task Force?

Aug 22, 2022 | Legal Update

Utah’s Mental Illness Psychotherapy Drug Task Force is active and operating, but what is it?  What is the task force doing? Who is on the task force, and why was it formed in the first place? You can find the answers to all of these questions below as we take a closer...

435-932-0633

Monday – Friday: 8:00 AM – 5:00 PM

Info@utahpatients.org